Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important

References

• Craske MG, Kircanski K, Epstein A, Wittchen H.U, Pine DS, Lewis-Fernández R, HintonD. DSM V anxiety; OC Spectrum; Posttraumatic and Dissociative Disorder Work Group. Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V. Depress. Anxiety 2010;27:93–112.
   Google Scholar
• Muñoz RF, Cuijpers P, Smit F, Barrera AZ, Leykin Y. Prevention of major depression. Annu Rev Clin Psychol 2010; 27:181–212.
   Google Scholar
• Nakashima MN, Ajiki K, Nakashima K, Takahashi M. Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice. J Pharmacol Sci 2003;91:47–52.
   PubMed Web of Science ®Google Scholar
• Markovitz JH, Shuster JL, Chitwood WS, May RS, Tolbert LC. Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry 2000;157:1006–8.
   PubMed Web of Science ®Google Scholar
• Ziegelstein RC, Parakh K, Sakhuja A, Bhat U. Depression and coronary artery disease: is there a platelet link? Mayo Clin Proc 2007;82:1366–8.
   Google Scholar
• Tiemeier H. Vitamin B12, folate and homocysteine in depression. The Rotterdam Study. Am J Psychiatry 2002;159:2099–101.
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhu DY. Neuronal nitric oxide synhase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009;20:223–30.
   PubMed Web of Science ®Google Scholar
• Joca SR, Guimaraes FS. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 2006;185:298–305.
   PubMed Web of Science ®Google Scholar
• Herken H, Uz E, Ozyurt H, . Red blood cell nitric oxide levels in patient with schizophrenia. Schizophr Res 2001; 52:289–90.
   PubMed Web of Science ®Google Scholar
• Miguel TT, Nunes-de-Souza RL. Anxiogenic like effects induced by NMDA receptor activation are prevented by inhibition or neuronal nitric oxide synthase in the periaqueductal gray in mice. Brain Res 2008;13:39–46.
   Google Scholar
• Workman JL, Trainor BC, Finy MS, . Inhibition of neuronal nitric oxide reduces anxiety-like responses to pair housing. Behav Brain Res 2008;187:109–15.
   PubMed Web of Science ®Google Scholar
• Bottiglieri T, Laundy M, Crellin R, . Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000;69:228–32.
   PubMed Web of Science ®Google Scholar
• Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Alternative Med Rev 2008;13:216–26.
   PubMed Web of Science ®Google Scholar
• Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest 1996;56:577–81.
   PubMed Web of Science ®Google Scholar
• Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J Chromatogr B Anal Technol Biomed Life Sci 2007;851: 51–70.
   PubMed Web of Science ®Google Scholar
• Born GV. Light on platelets. J Physiol 2005;1:713–14.
   Google Scholar
• Harkin A, Connor TJ, Walsh M, St John N, Kelly JP. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 200;44:616–23.
   Google Scholar
• Joca SR, Guimarães FS. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology (Berlin) 2006;185:298–305.
   PubMed Web of Science ®Google Scholar
• Chrapko W, Jurasz P, Radomski MW, Archer SL, Newman SC, Baker G, . Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology 2006;31: 1286–93.
   Web of Science ®Google Scholar
• Arslan A, Uzun M. Does the lower nitric oxide level cause cardiovascular changes in major depressed women? Eur Rev Med Pharmacol Sci 2008;12:309–13.
   Google Scholar
• Ikenouchi-Sugita A, Yoshimura R, Hori H, Umene-Nakano W, Ueda N, Nakamura J. Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1451–3.
   Web of Science ®Google Scholar
• Kim YK, Paik JW, Lee SW, Yoon D, Han C, Lee BH. Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1091–6.
   PubMedGoogle Scholar
• Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, . Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 2005;21:53–9.
   Google Scholar
• Kaya B, Unal S, Karabulut AB, Türköz Y. Altered diurnal variation of nitric oxide production in patients with panic disorder. Tohoku J Exp Med 2004;204:147–54.
   PubMed Web of Science ®Google Scholar
• Sánchez-Fernández C, González C, Mercer LD, Beart PM, Ruiz-Gayo M, Fernández-Alfonso MS. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic. J Cereb Blood Flow Metab 2003;23:364–70.
   Google Scholar
• Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res 1996;33:181–94.
   PubMed Web of Science ®Google Scholar
• Fantidis P. The role of the stress-related anti-inflammatory hormones ACTH and cortisol in atherosclerosis. Curr Vasc Pharmacol 2010;8:517–25.
   Google Scholar
• Stanger O, Weger M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 2003;41:1444–54.
   PubMed Web of Science ®Google Scholar
• Wallerath T, Witte K, Schäfer SC, Schwarz PM, Prellwitz W, Wohlfart P, . Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 1999;96;13357–62.
   PubMed Web of Science ®Google Scholar
• Rogers KM, Bonar CA, Estrella JL, Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol 2002;283:1922–8.
   PubMed Web of Science ®Google Scholar
• Markovitz JH, Matthews KA. Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom Med 1991;53:643–68.
   PubMed Web of Science ®Google Scholar
• von Känel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand 2004;110: 163–77.
   PubMed Web of Science ®Google Scholar
• Parakh K, Sakhuja A, Bhat U, Ziegelstein RC. Platelet function in patients with depression. South Med J 2008;101:612–27.
   PubMed Web of Science ®Google Scholar
• Ataoglu A, Canan F. Mean platelet volume in patients with major depression: effect of escitalopram treatment. J Clin Psychopharmacol 2009;29:368–71.
   PubMed Web of Science ®Google Scholar
• Chen CS, Chou MC, Yeh YC, Yang YH, Lai CL, Yen CF, . Plasma homocysteine levels and major depressive disorders in Alzheimer disease. Am J Geriatr Psychiatry 2010;18:1045–8.
   PubMed Web of Science ®Google Scholar
• Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C- > T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003;60:618–26.
   PubMed Web of Science ®Google Scholar
• Dittmann S, Seemüller F, Grunze HC. The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J Clin Psychiatry 2008;69:899–906.
   PubMed Web of Science ®Google Scholar
• Chellappa P, Ramaraj R. Depression, homocysteine concentration, and cardiovascular events. J Am Med Assoc 2009;301:1541–2.
   Google Scholar
• Meier C, Harbrecht U, Liedtke R, Oldenburg J, Conrad R, Imbierowicz K, . Relative hyperhomocysteinemia in patients with panic disorder: a case-control study. Neuropsychobiology 2010;62:164–70.
   Google Scholar
• Ravari H, Zafarghandi MR, Alvandfar D, Saadat S. Serum homocysteine in deep venous thrombosis, peripheral atherosclerosis and healthy Iranians: a case-control study. Pak J Biol Sci 2009;12:1019–24.
   PubMedGoogle Scholar
• Pasterkamp G, Algra A, Grobbee DE, de Jaegere PP, Banga JD, van der Graaf Y. Homocysteine and the stage of atherosclerotic disease: a study in patients suffering from clinically silent and clinically manifest atherosclerotic disease. Eur J Clin Invest 2002;32:309–15.
   PubMed Web of Science ®Google Scholar
• Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001;103:2717–23.
   PubMed Web of Science ®Google Scholar
• Medici V, Peerson JM, Stabler SP, . Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease. J Hepatol 2010;53:551–7.
   Google Scholar
• Unt E, Zilmer K, Mägi A. Homocysteine status in former top-level male athletes: possible effect of physical activity and physical fitness. Scand J Med Sci Sports 2008;18:360–6.
   PubMed Web of Science ®Google Scholar
• Nascimento CM, Stella F, Garlipp CR. Serum homocysteine and physical exercise in patients with Parkinson's disease. Psychogeriatrics 2011;11:105–12.
   PubMed Web of Science ®Google Scholar